Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT01504802
Eligibility Criteria:
Inclusion Criteria:
* Age greater than 3 years
* Prepubertal
* Height SD score less than -2.25
* Had a growth hormone stimulation test
Exclusion Criteria:
* History of any other disease or drug treatment that might interfere with linear growth, including amphetamine derivatives for treatment of ADD or ADHD
* Previous treatment with any growth-promoting medication, including growth hormone
* Any contraindication to growth hormone therapy
* Minor acute illness (upper respiratory infections, strep throat, gastroenteritis, urinary tract infection, etc.) less than one month prior to starting growth hormone
* Major acute illness (pneumonia, meningitis, pyelonephritis, any illness requiring hospitalization, etc.), any surgery, or bone fracture less than six months prior to starting growth hormone
* Weight less than 13 kg (NCC-J) or 15 kg (CHLA), due to blood volume being drawn.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Study:
NCT01504802
Study Brief:
Protocol Section:
NCT01504802